Additional file 1 of Splicing targeting drugs highlight intron retention as an actionable vulnerability in advanced prostate cancer
dataset
posted on 2024-02-28, 04:40 authored by Chiara Naro, Ambra Antonioni, Vanessa Medici, Cinzia Caggiano, Ariane Jolly, Pierre de la Grange, Pamela Bielli, Maria Paola Paronetto, Claudio SetteAdditional file 1: Supplementary Table 1. List of drugs used in the study, Supplementary Table 2. List of primers used in this study.
